Q

Quantum BioPharma Ltd
CNSX:QNTM

Watchlist Manager
Quantum BioPharma Ltd
CNSX:QNTM
Watchlist
Price: 14.12 CAD 2.39% Market Closed
Market Cap: 53.9m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of QNTM.

The Intrinsic Value is calculated as the average of DCF and Relative values:

QNTM Intrinsic Value
Not Available
Base Case Scenario
Compare QNTM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about QNTM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Quantum BioPharma Ltd

Current Assets 10.3m
Cash & Short-Term Investments 1.5m
Receivables 3.2m
Other Current Assets 5.6m
Non-Current Assets 5m
PP&E 228.2k
Intangibles 4.7m
Other Non-Current Assets -100
Current Liabilities 13.3m
Accounts Payable 1.9m
Accrued Liabilities 1.3m
Short-Term Debt 2.1m
Other Current Liabilities 7.9m
Non-Current Liabilities -1.7m
Other Non-Current Liabilities -1.7m
Efficiency

Free Cash Flow Analysis
Quantum BioPharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Quantum BioPharma Ltd

Revenue
0 USD
Operating Expenses
-18.7m USD
Operating Income
-18.7m USD
Other Expenses
-7.9m USD
Net Income
-26.6m USD
Fundamental Scores

QNTM Profitability Score
Profitability Due Diligence

Quantum BioPharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Quantum BioPharma Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

QNTM Solvency Score
Solvency Due Diligence

Quantum BioPharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
hidden
Solvency
Score

Quantum BioPharma Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

QNTM Price Targets Summary
Quantum BioPharma Ltd

Wall Street analysts forecast QNTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QNTM is 45.9 CAD with a low forecast of 45.45 CAD and a high forecast of 47.25 CAD.

Lowest
Price Target
45.45 CAD
222% Upside
Average
Price Target
45.9 CAD
225% Upside
Highest
Price Target
47.25 CAD
235% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Quantum BioPharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for QNTM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

QNTM News

Other Videos